Precision Haematological Cancer Medicine / (Record no. 73130)

000 -LEADER
fixed length control field 02608nam a2200505Ii 4500
001 - CONTROL NUMBER
control field 9781315380513
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220531132508.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 181112t20182019fluab ob 001 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781315380513
-- (e-book : PDF)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1056109109
040 ## - Cataloging Source
-- FlBoTFG
-- FlBoTFG
-- rda
041 1# -
-- eng
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number  RC280
Item number .H47
072 #7 -
-- MED
-- 002000
-- bisacsh
072 #7 -
-- MED
-- 062000
-- bisacsh
072 #7 -
-- MED
-- 038000
-- bisacsh
072 #7 -
-- MJCL
-- bicscc
082 04 -
--  616.99/418
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mughal, Tariq,
Relator term author.
245 10 - TITLE STATEMENT
Title Precision Haematological Cancer Medicine /
Statement of responsibility, etc. by Tariq Mughal.
250 ## - EDITION STATEMENT
Edition statement First edition.
264 #1 -
-- Boca Raton, FL :
-- CRC Press,
-- [2018].
264 #4 -
-- ©2019.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (241 pages) :
Other physical details 193 illustrations, text file, PDF
336 ## -
-- text
-- rdacontent
337 ## -
-- computer
-- rdamedia
338 ## -
-- online resource
-- rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 00 -
-- Precision Medicine and Future Therapeutics. Classifications and Risk Factors. Historical Milestones. Acute Myeloid Leukaemia. Acute Lymphoblastic Leukaemia. Chronic Myeloid Leukaemia. Myeloproliferative and Related Neoplasms. Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms. Leukaemias of Mature B- and T/NK-Cells. Hodgkin Lymphoma. Non-Hodgkin Lymphoma. Plasma Cell Neoplasms. Principal Treatment-Related Side Effects. Concluding Thoughts.
520 3# -
-- Many experts now consider genetic evaluation to be pivotal for the optimal diagnosis, classification, risk stratification, and therapeutic decision-making for persons diagnosed with blood cancer. This new text specifically focuses on the genetic alterations essential for establishing diagnosis and assesses how they might impact the precision oncology standard of care. Providing an authoritative review of the state of the art, this is essential reading for physicians, hematologists, and oncologists for optimal management of individual patients.
530 ## -
-- Also available in print format.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Blood
General subdivision Cancer.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Blood
General subdivision Cancer
-- Treatment.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Hematologic Neoplasms.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Precision Medicine.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Oncology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Hematology.
Source of heading or term bisacsh
655 #0 -
-- Electronic books.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Taylor and Francis.
776 08 -
-- Print version:
-- 9781138348424
856 40 -
-- https://www.taylorfrancis.com/books/9781315380513
-- Click here to view.

No items available.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571